茶饮小料
Search documents
一致魔芋:北交所信息更新:魔芋原料高位毛利率暂承压,看好茶饮小料、健康品潜力-20260331
KAIYUAN SECURITIES· 2026-03-31 10:24
Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Insights - The company reported a revenue of 739 million yuan for 2025, representing a year-on-year growth of 19.91%, while the net profit attributable to the parent company was 66.72 million yuan, down 23.05% year-on-year due to rising raw material costs [2] - The gross margin for 2025 was 19.99%, a decline of 6.66 percentage points compared to 2024's 26.65% [2] - The company is expected to see net profits of 90 million yuan, 112 million yuan, and 136 million yuan for 2026, 2027, and 2028 respectively, with corresponding EPS of 0.87, 1.09, and 1.32 yuan per share [2] - The company is optimistic about the potential of its 80,000-ton crystal ball project and other fundraising projects [2] Revenue and Profitability - The company achieved a revenue of 5.15 billion yuan from konjac powder in 2025, an increase of 18.74% year-on-year, with a gross margin of 20.24%, down 4.91 percentage points [3] - The konjac food segment generated revenue of 2.13 billion yuan, up 24.38% year-on-year, with a gross margin of 19.21%, down 10.22 percentage points [3] - The tea beverage small material business has shown rapid growth in recent years [3] Research and Development - The company increased its R&D expenses by 16% in 2025, totaling 27.67 million yuan, and holds 28 invention patents [4] - The company focuses on innovation-driven development and has established a product innovation system based on market demand [4] Financial Summary and Valuation Metrics - The projected revenue for 2026 is 864 million yuan, with a year-on-year growth of 16.9% [5] - The projected net profit for 2026 is 90 million yuan, with a year-on-year growth of 34.2% [5] - The gross margin is expected to improve to 21.8% in 2026 [5] - The P/E ratios for 2026, 2027, and 2028 are projected to be 24.2, 19.3, and 15.9 respectively [5]
一致魔芋(920273):魔芋原料高位毛利率暂承压,看好茶饮小料、健康品潜力
KAIYUAN SECURITIES· 2026-03-31 09:16
Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Insights - The company reported a revenue of 739 million yuan for 2025, representing a year-on-year growth of 19.91%, while the net profit attributable to shareholders was 66.72 million yuan, down 23.05% year-on-year due to rising raw material costs [2][3] - The gross margin for 2025 was 19.99%, a decline of 6.66 percentage points compared to 2024's 26.65% [2] - The company is expected to see net profits of 90 million yuan in 2026, 112 million yuan in 2027, and 136 million yuan in 2028, with corresponding EPS of 0.87, 1.09, and 1.32 yuan per share [2][5] Financial Performance Summary - Revenue for 2025 was 739 million yuan, with a year-on-year growth of 19.9% [5] - The net profit attributable to shareholders for 2025 was 66.72 million yuan, reflecting a year-on-year decline of 23.1% [5] - The gross margin for 2025 was 20.0%, down from 26.7% in 2024 [5] - The company’s R&D expenses increased by 16.32% in 2025, totaling 27.67 million yuan [4] - The company has 90 intellectual property rights, including 28 invention patents [4] Revenue and Profit Forecast - Projected revenues for 2026, 2027, and 2028 are 864 million yuan, 1.078 billion yuan, and 1.255 billion yuan, respectively [5] - Projected net profits for the same years are 90 million yuan, 112 million yuan, and 136 million yuan, with corresponding P/E ratios of 24.2, 19.3, and 15.9 [5][7]
一致魔芋(920273):Q3收入较快增长,毛利率实现筑底,新产能将陆续投产
Shenwan Hongyuan Securities· 2025-10-29 14:13
Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company reported a revenue of 569 million yuan for the first three quarters of 2025, representing a year-on-year increase of 30.5%. The net profit attributable to shareholders was 62 million yuan, up 0.5% year-on-year [5][8] - In Q3 2025, the company achieved a revenue of 210 million yuan, a 20.5% increase year-on-year, while the net profit decreased by 25.6% to 21 million yuan [5][8] - The company is expected to benefit from new production capacities being released, which will help capture market opportunities [8] Financial Summary - The total revenue forecast for 2025 is 790 million yuan, with a year-on-year growth rate of 28.1%. The net profit is projected to be 93 million yuan, reflecting a growth rate of 6.9% [7] - The gross profit margin for Q3 2025 was 20.0%, down 5.3 percentage points year-on-year but showing a recovery from the previous quarter [8] - The company plans to increase its production capacity for konjac products, with a new production line expected to be operational by December 2025, increasing annual capacity from 5,700 tons to 10,200 tons [8]